Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Gene-specific Ebola therapies protect non-human primates from lethal disease

Gene-specific Ebola therapies protect non-human primates from lethal disease

January 13, 2006

Scientists have developed a successful strategy for interfering with Ebola virus infection that protected 75 percent of nonhuman primates exposed to the lethal disease. This is the first successful antiviral intervention against filoviruses like Ebola in nonhuman primates. The findings could serve as the basis for a new approach to quickly develop virus-specific therapies for known, emerging, and genetically engineered pathogens.

In today's online issue of the journal Public Library of Science Pathogens, a research team led by Sina Bavari and colleagues at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) reports using novel "antisense" drugs to interrupt normal Ebola virus replication. The work was performed in collaboration with AVI BioPharma, a U.S. biotechnology firm.




According to the study's authors, antisense drugs are useful against viral diseases because they are designed to enter cells and eliminate viruses by preventing their replication. The drugs, which act by blocking critical viral genetic sequences, may be more potent than anti-virals such as protease inhibitors, which seek to inhibit a protein needed for viral replication.

Ebola virus causes hemorrhagic fever with case fatality rates as high as 80 percent in humans. The virus, which is infectious by aerosol (although more commonly spread through blood and bodily fluids of infected patients), is of concern both as a global health threat and a potential agent of biological warfare or terrorism. Currently there are no available vaccines or therapies.

"One advantage of this strategy is that it directly targets the virus," said the paper's first author, Kelly L. Warfield. "With Ebola infection, the virus grows so fast that it overtakes the host immune system. What we did, essentially, was to hold off the viral replication long enough for the host to mount an immune response and clear the virus."

Working with a class of compounds known as antisense phosphorodiamidate morpholino oligomers, or PMOs, the team first performed a series of studies to identify PMOs that demonstrated activity against Ebola virus. Next, three of the PMOs were tested in mice, both individually and in combination. The combination of all three was found to be the most effective therapeutic approach in mice, whether the PMOs were administered before or after Ebola infection. Combination therapy was also tested in guinea pigs, where it appeared to be most effective when administered after infection.

To further evaluate the efficacy of the three-PMO combination, four rhesus monkeys were treated with the drug two days prior to Ebola virus exposure. Three of the four were protected from Ebola infection.

"These results, while preliminary, are very encouraging," said Colonel George W. Korch, USAMRIID commander, "especially when you consider that Ebola virus has, to date, been fairly intractable to effective treatment. We look forward to additional findings of success using these PMOs."

US Army Medical Research Institute of Infectious Diseases



Related Ebola Current Events and Ebola News Articles Ebola Current Events and Ebola News RSS Ebola Current Events and Ebola News RSS
1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.

Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice
An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.

Outfoxing pox: Developing a new class of vaccine candidates
In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox.

World will miss 2010 target to stem biodiversity loss, experts say
The world will miss its agreed target to stem biodiversity loss by next year, according to experts convening in Cape Town for a landmark conference devoted to biodiversity science.

Scientists block Ebola infection in cell-culture experiments
Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.

OHSU scientists partner with others to form center aimed at combating infectious diseases
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.

Drug blocks 2 of world's deadliest emerging viruses
Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology.

Penn Study Identifies How Ebola Virus Avoids the Immune System
Researchers at the University of Pennsylvania School of Medicine have likely found one reason why the Ebola virus is such a powerful, deadly, and effective virus. Using a cell culture model for Ebola virus infection, they have discovered that the virus disables a cellular protein called tetherin that normally can block the spread of virus from cell to cell.

Iowa State University researchers discover structure of key Ebola protein
Research led by Iowa State University scientists has them a step closer to finding a way to counter the Ebola virus.

UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs
Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.
More Ebola Current Events and Ebola News Articles
Ebola: Through the Eyes of the People

Ebola: Through the Eyes of the People
by William T. Close (Author)

At a Catholic Mission in Yambuku, an oasis of peace and efficiency in northern Congo's vast jungle forests, Mabalo Lokela, a teacher, receives an anti-malarial shot for a raging fever and headache. Sister Lucie, a Flemish nursing sister, swishes out a syringe with a weak disinfectant. The next patients are injected with the same syringe and the sick man's virus spreads.

Lokela was the first Congolese victim of a new African hemorrhagic disease that became known as Ebola fever. When Sister Lucie dies a few days later, panic erupts and hospitalized patients flee into the forest. With the convent connected to the outside world by a single primitive radio, the mission nuns can only pray and wonder if anyone will act on their cries for help.

NOVA: Ebola - The Plague Fighters

NOVA: Ebola - The Plague Fighters
Starring: Nova
Directed By: Nova

Enter the "hot zone" of one of the most frightful diseases on the planet- Ebola.

When a dreaded outbreak of the deadly Ebola virus swept through a remote region of Zaire in May 1995, NOVA was the only film crew permitted into the "hot zone." Spending a total of four weeks in the quarantined city of Kikwit, the result is unprecedented journalistic coverage of this grim battle against one of the world's most lethal diseases.

The Ebola plague kills a very high percentage of its victims (77% in Kikwit), often by dissolving their internal organs and connective tissue. Learn how disease specialists traced the origins of the outbreak by compiling a complete "chain of death" of the epidemic, and why they fear a mutation of Ebola will emerge that is even more difficult to contain.

EBOLA GIANT MICROBE PLUSH

EBOLA GIANT MICROBE PLUSH
by Giant Microbes

Since its discovery in 1976, Ebola has become the T. Rex of microbes.
Share the love!

Ebola

Ebola
by Dr. William Close (Author)

IT STRIKES WITHOUT WARNING--A HORRIFYING, LETHAL DISEASE WITH NO NAME. AND NO CURE. . . .

Now, from the molten center of the "hot zone," comes a terrifying, completely authentic novel of medical suspense by William T. Close, M.D., the American physician who lived in Zaire for sixteen years, and who worked desperately to contain the first outbreak of the virus in 1976. Haunted by the images from this wrenching time, and unable to forget the people he knew and lost, Dr. Close was compelled to tell their story. EBOLA, inspired by his personal experience and based upon extensive research, is an unforgettable portrait of this devastating drama, which all began with an invisible, unknown killer . . . .

EBOLA

At a Catholic mission in Yambuku, a remote area of Zaire, Mabalo Lokela, a local...

Emerging Viruses: AIDS And Ebola : Nature, Accident or Intentional?

Emerging Viruses: AIDS And Ebola : Nature, Accident or Intentional?
by Leonard G. Horowitz (Author)



Ebola Syndrome

Ebola Syndrome
Starring: Anthony Wong Chau-Sang, Yeung Ming Wan, Fui-On Shing, Wong Tsui-ling, Miu-Ying Chan
Directed By: Herman Yau
Also With: Jing Wong (Producer), Ting Chau (Writer)


Region 1
Original Cantonese Language
Optional English Subtitles
Dolby Digital audio
16 x 9 Anamorphic Widescreen
Original 1.85:1 Aspect Ratio
Theatrical Trailer
Photo Gallery
Audio commentary with Anthony Wong and Herman Yau
Interview with the director Herman Yau
Never before seen deleted scenes!


Kai San is a sleazy and despicable bastard of the most epic proportions! After being caught screwing the wife of his boss, he goes on a killing spree and flees Hong Kong. 10 years later, Kai finds himself working as a restaurant chef in South Africa. Overworked, underpaid, berated, and extorted by the restaurant owners who know of his fugitive status, Kai is a ticking timebomb...

While visiting an ebola infected...

The Hot Zone: A Terrifying True Story

The Hot Zone: A Terrifying True Story
by Richard Preston (Author)

A highly infectious, deadly virus from the central African rain forest suddenly appears in the suburbs of Washington, D.C. There is no cure. In a few days 90 percent of its victims are dead. A secret military SWAT team of soldiers and scientists is mobilized to stop the outbreak of this exotic "hot" virus. The Hot Zone tells this dramatic story, giving a hair-raising account of the
appearance of rare and lethal viruses and their "crashes" into the human race. Shocking, frightening, and impossible to ignore, The Hot Zone proves that truth really is scarier than fiction.


From the Paperback edition.

Ebola Mini Plush in Petri Dish by Giant Microbes [Toy]

Ebola Mini Plush in Petri Dish by Giant Microbes [Toy]
by Giant Microbes

GIANTmicrobes are stuffed animals that look like tiny microbes only a million times actual size! They're humorous, educational, and fun! Each of our GIANTmicrobes comes with an image and information about the real microbe it represents. They make great learning tools, as well as amusing gifts for anyone with a sense of humor. 3 Minis per petri dish. Each measures Approx. 3" Made in China

NOVA: Epidemic - Ebola, AIDS, Bird Flu and Typhoid

NOVA: Epidemic - Ebola, AIDS, Bird Flu and Typhoid
Starring: Nova
Directed By: Nova

Includes four programs: NOVA-Ebola The Plague Fighters; NOVA-Surviving AIDS, NOVA-Typhoid Mary: The Most Dangerous Woman in America; and Rx for Survival-Bird Flu.

Ebola (Deadly Diseases and Epidemics)

Ebola (Deadly Diseases and Epidemics)
by Tara C. Smith (Author)



© 2009 BrightSurf.com